Funded Tech Companies
Myricx Bio
Myricx Bio is a life sciences company, based in London. Financial backing came from Eli Lilly and Company, Brandon Capital Partners and Sofinnova Partners.
Company Overview
Company Name
Myricx Bio
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Gridiron Building, 1 Pancras Square, King's Cross
London, N1C 4AG
UK
London, N1C 4AG
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Myricx Bio ("Myricx") is a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. NMT is an enzyme that adds a specific lipid modification to a number of protein targets key to cancer cell survival.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/8/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Ed Tate
Chief Executive Officer
Robin Carr
Chief Operating Officer
Julie Mead
Chief Scientific Officer
Francesca Zammarchi
Co-Founder
Andrew Bell
Co-Founder
Roberto Solari
Vice President
Robert McLeod
VP - Operations
Nikki D'Arcy
Company Investors
- Eli Lilly and Company
- Brandon Capital Partners
- Sofinnova Partners
- Abingworth
- British Patient Capital
- Novo Holdings
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs